The role of transcriptional factor brachyury in the development and repair of nucleus pulposus
Department of Orthopeadic Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, 215002, China
*Address correspondence to: Jun Shen, email@example.com
#These authors contributed equally to this work
Received: 19 June 2021; Accepted: 02 September 2021
Abstract: Transcription factor Brachyury, a protein containing 435 amino acids, has been widely investigated and reported in notochord differentiation and nucleus pulposus development. The crucial functions and underlying mechanisms by Brachyury are discussed in this paper, which suggests Brachyury can be developed into a potential novel target for the therapy of intervertebral disc degeneration.
Keywords: Brachyury; Nucleus pulposus; Notochord; IVD
|iPSC:||Induced pluripotent stem cells|
|PSM:||Primitive streak mesoderm|
Current therapeutic modalities for low back pain arising from intervertebral disc (IVD) degeneration mainly target the symptoms alleviation while failing to treat the underlying disease pathology (Tang et al., 2021).
Various studies have attempted to develop early-stage intervention to retard and reverse the IVD degeneration process. Recapitulation of the embryonic patterning process of the IVD may help develop novel biological repair approaches for disc degeneration (Cornejo et al., 2015). The central nucleus pulposus (NP) tissue plays a pivotal role in maintaining the function of IVD. It is the mainly affected structure in IVD degeneration (Rodrigues-Pinto et al., 2014), which demonstrates decreased cellularity, water content and proteoglycans.
Various studies have evidenced that the entire cell subpopulations of the NP are descended from the embryonic notochord (Shapiro and Risbud, 2010). The transcriptional factors playing vital roles in the notochord development have been attempted to rescue the function of degenerated nucleus pulposus cells.
Transcription factor Brachyury, a protein of 435 amino acids, binds with the canonical T-domain DNA sequence: TCACACCT. Brachyury regulates posterior mesoderm formation and notochord differentiation by directly activating downstream mesoderm-specific genes (Chen et al., 2020a; Chen et al., 2020b; Xu et al., 2020). The embryonic notochord is considered to be the developmental origin of mature adult NP tissue (Richardson et al., 2017). Brachyury has widely been recognized as the specific marker for the notochordal (NC) cells (Tang et al., 2016). The human notochord and juvenile NP are populated by larger and vacuolated NC cells, which gradually disappear and are replaced by a population of small and round “chondrocyte-like” NP cells after puberty (Risbud et al., 2015). There is a long-held controversy on the ontogeny and heterogeneity of morphologically distinct NC and NP cells. Minogue et al. (2010) found NP cells isolated from adult bovine and human discs also expressed Brachyury, the mRNA level expression remained unchanged in the degenerated human nucleus pulposus, which is suggestive of a common ontogeny of the NP and NC cells. Further study by Richardson et al. (2017) showed Brachyury protein was expressed in the cells of adult human nucleus pulposus tissue, but significantly lower positivity was demonstrated in mature adult compared to young and significantly lower positivity in severely degenerated tissues compared to non-degenerated. Various convincing evidence suggest that most cells in adult nucleus pulposus tissue differentiate along the notochordal lineage, morphological differences of NC and NP cells represent different physiological or pathological stages of aging and degeneration (Risbud et al., 2015). Brachyury, a traditional marker of NC cells, has been considered as a critical phenotypic marker of healthy NP (Risbud et al., 2015) and helps to evidence the homology of NC and NP cells.
Several studies have reported that Brachyury was transfected into degenerated NP cells or human induced pluripotent stem cells (iPSC), aiming to promote these cells to transmit or differentiate into healthy NP cells, which can produce more extracellular matrix and restore the homeostasis of disc microenvironment. Brachyury lent virus transfection promoted and enhanced the differentiation of human iPSC toward NP-like cells in vitro (Tang et al., 2018). Tang et al. (2019) demonstrated nonviral Brachyury transfection into mildly degenerated human NP cells promoted the phenotype transition into a pro-anabolic and anti-catabolic/inflammatory one, and significantly increased glycosaminoglycan accumulation in vitro, which suggests Brachyury has the potential to be developed into an useful target for the treatment of IVD degeneration. Sheyn et al. (2019) reported stepwise differentiation strategy of human iPSCs into NC cells. Brachyury-encoding plasmids were nucleofected into primitive streak mesoderm (PSM) cells, which were induced and differentiated from iPSCs, to acquire NC cells. Further testing in vivo in the porcine model showed that the acquired NC cells had a protective role on discs from degeneration.
We have found that Brachyury can promote proteoglycan synthesis by nucleus pulposus cells. Whether Brachyury transfection into remaining degenerated nucleus pulposus cells or exogenously sourced cells can facilitate the transition toward a healthy nucleus pulposus phenotype in the harsh degenerated disc microenvironment requires more in-depth investigations.
Author Contribution: The authors confirm contributions to the paper as follows: study conception and design: Jun Shen; data collection: Yinghui Wu and Hong Zhang; draft manuscript preparation: Qiang Wang and Suoyuan Li. All authors reviewed and approved the final version of the manuscript.
Funding Statement: This work was supported by the Gusu Health Talent Project of Suzhou (Grant No. GSWS2020056) and “333” Talent Project of Jiangsu Province (Grant No. BRA2017057).
Conflicts of Interest: The authors declare that they have no conflicts of interest to report regarding the present study.
|This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.|